scispace - formally typeset
L

Livia Di Renzo

Researcher at Sapienza University of Rome

Publications -  37
Citations -  6196

Livia Di Renzo is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Programmed cell death & Apoptosis. The author has an hindex of 18, co-authored 37 publications receiving 5639 citations. Previous affiliations of Livia Di Renzo include Policlinico Umberto I.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Increased T-helper interferon-γ-secreting cells in obese children

TL;DR: In obese children, a shift to Th1-cytokine profile dominated by the production of IFN-g is related to insulin resistance as well as to NASH independently of anthropometric features and other metabolic characteristics.
Journal ArticleDOI

COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment.

TL;DR: The association between TxB(2) production and either fasting plasma glucose and HbA1c levels suggests that in diabetic patients hyperglycaemia is a determinant of the reduced platelet sensitivity to aspirin.
Journal Article

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2459 more
- 01 Jan 2016 - 
Journal ArticleDOI

Primary effusion lymphoma cell death induced by bortezomib and AG 490 activates dendritic cells through CD91.

TL;DR: Both treatments were able to induce PEL apoptosis with similar kinetics and promote dendritic cells (DC) maturation and it was found that PEL cell death induced by Bortezomib was more effective in inducing uptake by DC compared to AG 490 or combination of both drugs.